FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128160816> ?p ?o ?g. }

• W2128160816 endingPage "1447" @default.
• W2128160816 startingPage "1441" @default.
• W2128160816 abstract "Objective— Transthyretin can cause amyloidosis attributable to destabilization of transthyretin tetramers in plasma. We tested the hypothesis that genetic stabilization of transthyretin associates with reduced risk of vascular disease and increased life expectancy. Approach and Results— We included 68 602 participants from 2 prospective studies of the general population. We genotyped for 2 stabilizing genetic variants in the transthyretin gene ( TTR ), R104H and T119M, and determined the association of genotypes with plasma levels of transthyretin, measures of thyroid function, risk of vascular disease, and life expectancy. During a mean follow-up of 32 years, 10 636 participants developed vascular disease. We identified 321 heterozygotes for T119M (frequency, 0.47%); R104H was not detected. First, mean plasma transthyretin and thyroxine levels were increased by 17% (26 µg/mL) and 20% (19 nmol/L), respectively, in heterozygotes versus noncarriers ( P =0.007 and P <0.0001), demonstrating functionality of this variant in the general population. Second, corresponding hazard ratios were 0.70 (95% confidence interval, 0.51–0.97) for all vascular diseases, 0.85 (0.59–1.23) for cardiovascular disease, 0.45 (0.25–0.81) for cerebrovascular disease, 0.47 (0.25–0.88) for ischemic cerebrovascular disease, and 0.31 (0.04–2.22) for hemorrhagic stroke. The cumulative incidence of cerebrovascular disease as a function of age was decreased in heterozygotes versus noncarriers ( P =0.005). Third, median age at death from all causes, from vascular and cerebrovascular diseases, and after diagnosis of vascular disease, and median age at diagnosis of vascular disease, was increased by 5 to 10 years in heterozygotes versus noncarriers ( P =0.002–0.05). Conclusions— These results are compatible with an association between genetic stabilization of transthyretin and decreased risk of cerebrovascular disease, and with increased life expectancy in the general population." @default.
• W2128160816 created "2016-06-24" @default.
• W2128160816 creator A5000575297 @default.
• W2128160816 creator A5022615366 @default.
• W2128160816 creator A5079728437 @default.
• W2128160816 creator A5081108450 @default.
• W2128160816 date "2013-06-01" @default.
• W2128160816 modified "2023-09-26" @default.
• W2128160816 title "Genetic Stabilization of Transthyretin, Cerebrovascular Disease, and Life Expectancy" @default.
• W2128160816 cites W1551114423 @default.
• W2128160816 cites W1567317153 @default.
• W2128160816 cites W163987580 @default.
• W2128160816 cites W1648126347 @default.
• W2128160816 cites W1938687031 @default.
• W2128160816 cites W1972373816 @default.
• W2128160816 cites W1972417329 @default.
• W2128160816 cites W1974280458 @default.
• W2128160816 cites W1974469329 @default.
• W2128160816 cites W1978632887 @default.
• W2128160816 cites W1982340002 @default.
• W2128160816 cites W2014466762 @default.
• W2128160816 cites W2015219413 @default.
• W2128160816 cites W2019261756 @default.
• W2128160816 cites W2022945618 @default.
• W2128160816 cites W2024615249 @default.
• W2128160816 cites W2032556980 @default.
• W2128160816 cites W2042975557 @default.
• W2128160816 cites W2049336811 @default.
• W2128160816 cites W2050262822 @default.
• W2128160816 cites W2058078504 @default.
• W2128160816 cites W2060449610 @default.
• W2128160816 cites W2066486669 @default.
• W2128160816 cites W2068916005 @default.
• W2128160816 cites W2069140392 @default.
• W2128160816 cites W2085354241 @default.
• W2128160816 cites W2092180837 @default.
• W2128160816 cites W2095238968 @default.
• W2128160816 cites W2102450498 @default.
• W2128160816 cites W2107491044 @default.
• W2128160816 cites W2116622558 @default.
• W2128160816 cites W2131999691 @default.
• W2128160816 cites W2134010906 @default.
• W2128160816 cites W2154948750 @default.
• W2128160816 cites W2158907165 @default.
• W2128160816 cites W2160930399 @default.
• W2128160816 cites W2171264766 @default.
• W2128160816 cites W2319723388 @default.
• W2128160816 doi "https://doi.org/10.1161/atvbaha.113.301273" @default.
• W2128160816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23580146" @default.
• W2128160816 hasPublicationYear "2013" @default.
• W2128160816 type Work @default.
• W2128160816 sameAs 2128160816 @default.
• W2128160816 citedByCount "43" @default.
• W2128160816 countsByYear W21281608162013 @default.
• W2128160816 countsByYear W21281608162014 @default.
• W2128160816 countsByYear W21281608162015 @default.
• W2128160816 countsByYear W21281608162016 @default.
• W2128160816 countsByYear W21281608162017 @default.
• W2128160816 countsByYear W21281608162018 @default.
• W2128160816 countsByYear W21281608162019 @default.
• W2128160816 countsByYear W21281608162020 @default.
• W2128160816 countsByYear W21281608162021 @default.
• W2128160816 countsByYear W21281608162022 @default.
• W2128160816 countsByYear W21281608162023 @default.
• W2128160816 crossrefType "journal-article" @default.
• W2128160816 hasAuthorship W2128160816A5000575297 @default.
• W2128160816 hasAuthorship W2128160816A5022615366 @default.
• W2128160816 hasAuthorship W2128160816A5079728437 @default.
• W2128160816 hasAuthorship W2128160816A5081108450 @default.
• W2128160816 hasBestOaLocation W21281608161 @default.
• W2128160816 hasConcept C121157162 @default.
• W2128160816 hasConcept C126322002 @default.
• W2128160816 hasConcept C127413603 @default.
• W2128160816 hasConcept C133925201 @default.
• W2128160816 hasConcept C134018914 @default.
• W2128160816 hasConcept C164705383 @default.
• W2128160816 hasConcept C188816634 @default.
• W2128160816 hasConcept C207103383 @default.
• W2128160816 hasConcept C2777466421 @default.
• W2128160816 hasConcept C2779134260 @default.
• W2128160816 hasConcept C2780645631 @default.
• W2128160816 hasConcept C2908647359 @default.
• W2128160816 hasConcept C44249647 @default.
• W2128160816 hasConcept C71924100 @default.
• W2128160816 hasConcept C78519656 @default.
• W2128160816 hasConcept C90924648 @default.
• W2128160816 hasConcept C99454951 @default.
• W2128160816 hasConceptScore W2128160816C121157162 @default.
• W2128160816 hasConceptScore W2128160816C126322002 @default.
• W2128160816 hasConceptScore W2128160816C127413603 @default.
• W2128160816 hasConceptScore W2128160816C133925201 @default.
• W2128160816 hasConceptScore W2128160816C134018914 @default.
• W2128160816 hasConceptScore W2128160816C164705383 @default.
• W2128160816 hasConceptScore W2128160816C188816634 @default.
• W2128160816 hasConceptScore W2128160816C207103383 @default.
• W2128160816 hasConceptScore W2128160816C2777466421 @default.
• W2128160816 hasConceptScore W2128160816C2779134260 @default.
• W2128160816 hasConceptScore W2128160816C2780645631 @default.

• next